Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Gastrointestinal Drugs. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover the advanced production method for omeprazole intermediate CN114044752A. Achieve higher yields, reduced costs, and reliable supply chain solutions for pharmaceutical manufacturing.
Patent CN107915720B reveals a greener Vonoprazan route. Discover cost reduction in API intermediate manufacturing and reliable supply chain solutions.
Patent CN113512026A reveals a high-yield synthesis route for Esomeprazole Sodium. Discover cost-effective manufacturing and supply chain advantages for pharmaceutical intermediates.
Patent CN102146079A reveals a solvent-free quaternization process enhancing yield to 82%. Discover cost reduction in API manufacturing and supply chain reliability.
Patent CN109912569B reveals a mild, high-yield route for Esomeprazole Magnesium. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN113896655A reveals a telescoped toluene-based route for Vonoprazan intermediate, offering >99.5% purity and scalable manufacturing for global supply chains.
Discover the novel cobalt-catalyzed reductive amination route for Vonoprazan Fumarate. Enhanced yield, simplified process, and cost-effective manufacturing for global supply chains.
Discover a novel high-yield synthesis for S-pantoprazole sodium using sodium bismuthate. Enhanced optical purity and cost-effective manufacturing for global supply chains.
Novel Mitsunobu-based route for Gefarnate eliminates toxic solvents like DMF, offering high purity and scalable manufacturing for pharmaceutical supply chains.
Patent CN108341775B reveals a streamlined Minisci reaction for Rebamipide intermediates, offering significant cost reduction and simplified supply chain management for pharmaceutical manufacturers.
Novel patent CN103664887B enables high-purity Esomeprazole Sodium production. Eliminating toxic solvents ensures cost reduction and supply chain reliability for global pharmaceutical partners.
Patent CN102260244B details a stable rabeprazole sodium synthesis with 99.9% purity. Offers superior moisture stability and cost-effective manufacturing for global supply chains.
Patent CN115991738A details a novel solid-phase synthesis for Plecanatide using orthogonal S-Tmp and Acm protection, ensuring high purity and commercial scalability for pharmaceutical manufacturers.
Advanced isothermal purification method for Esomeprazole Sodium achieving >99.5% purity. Reduces solvent residue and ensures supply chain stability for global API manufacturers.
Patent CN113444150B reveals a novel solid-phase method for Plecanatide, offering superior yield and purity. Discover cost-effective manufacturing solutions for this GI drug.
Patent CN103044402B details a low-cost chiral oxidation route for Esomeprazole Sodium, offering high purity and supply chain stability for API manufacturing.
Novel low-cost route for Itopride HCl using N,N-dimethylethanolamine. Reduces cost by 30% and avoids high-pressure hydrogenation for scalable API manufacturing.
Patent CN102603716A details a novel titanium-catalyzed asymmetric oxidation for (S)-pantoprazole. Achieve 100% ee value with streamlined processing for reliable pharmaceutical intermediate supply.
Solve impurity challenges in flunaprazan intermediate production. 99.82% HPLC purity, 0.07% max impurity, 30% cost reduction. Scale to 100 MT/yr.